Clinical Trials Directory

Trials / Completed

CompletedNCT06239766

BC Risk Assessment Before Top Surgery

Assessing Breast Cancer Risk Prior to Gender-Affirming Chest Masculinization Surgery in Transgender and Gender-Diverse Persons

Status
Completed
Phase
Study type
Observational
Enrollment
25 (actual)
Sponsor
Medical College of Wisconsin · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Accepted

Summary

The population of transgender and gender-diverse (TGD) persons in Wisconsin and the U.S. is steadily increasing. As this population grows, the number of individuals seeking gender-affirming therapies, including gender-affirming operations and gender-affirming hormone therapy, is also growing. An example of gender-affirming surgery is chest masculinization surgery, in which most breast tissue is removed in a person assigned female or intersex at birth to allow the chest to appear masculine. Gender-affirming chest masculinization surgery is not generally considered equivalent to an oncologic mastectomy, which aims to removal all breast tissue for future breast cancer reduction or current breast cancer treatment. The goals of this investigation are to 1) determine the percent of TGD persons considering chest masculinization surgery who have an elevated lifetime risk of breast cancer development and/or a pathogenic genetic mutation; 2) measure the percent who are at risk and choose to undergo risk-reducing mastectomies as part of chest masculinization surgery; and 3) assess and compare self-perceived breast cancer risk with calculated risk. The results of this study will substantially inform TGD patients and surgeons on the utility of personalized breast cancer risk assessment prior to chest masculinization surgery and the accuracy of self-perceived breast cancer risk in TGD persons.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTBreast Cancer Risk AssessmentGail and IBIS Tools will be utilized to calculate mean lifetime breast cancer risk

Timeline

Start date
2023-03-15
Primary completion
2023-12-29
Completion
2024-02-01
First posted
2024-02-02
Last updated
2024-03-13

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06239766. Inclusion in this directory is not an endorsement.

BC Risk Assessment Before Top Surgery (NCT06239766) · Clinical Trials Directory